Susan Hasty, Publisher
Table of Contents . . . September 18th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Vaccine Weekly | Other Publications
Cancer Vaccine - Vaccine that targets human chorionic gonadotropin extends colorectal cancer patient survival
Human Papillomavirus - Mumps vaccine induces remission in patients with recurrent respiratory papilloma
Ebola Virus - Vaccine effective in mice with cell-mediated immune function
HIV Prevention - Promising multistrain HIV vaccine candidate emerges
Influenza Vaccine - Interventional program dramatically increases influenza vaccination rates among the elderly
Vaccinia Virus Vaccine - A recombinant vaccinia virus Lister shows promise as a vaccine vector
AIDS Therapy - The Immune Response Corp. announces results from Remune trial
Finance - Net loss reported at CAN$0.34 per share
Finance - Protein Sciences announces first half results revenues increase 59%
Group B Streptococcus - Sequence provides insights into pathogen's virulence mechanism
Hemorrhagic Fevers - Ebola vaccine agreement expanded to include Marburg, Lassa vaccines
Influenza - Flu shot benefits outweigh costs in healthy young adults
Meningococcal Meningitis - Parents urged to learn about campus meningitis risk
Poliomyelitis - 9.5M vaccine doses donated to Global Eradication Initiative
Poliomyelitis - Baxter grants $200,000 to global polio eradication initiative
Research Funding - Bioterror threat a focus of UMD vaccine research contract
Research Issues - Twenty years of monkey research boosts AIDS knowledge
Respiratory Infection - MedImmune licenses rights to newly discovered human metapneumovirus
Traveler's Diarrhea - ProdiGene, NIH begin study on oral vaccine derived from transgenic corn
Vaccine Prophylaxis - Measles, varicella, and influenza immunizations recommended for adult cancer patients
Varicella - Pennsylvania, Michigan add vaccination requirement for school-age children
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.